2. Share Prices
3. Glaxosmithkline Share Price
4. Glaxosmithkline Share News
5. UK earnings, trading statements calendar - next 7 days

Glaxosmithkline Share News (GSK)

• GSK Share
  Price
• GSK Share
  News0
• GSK Share
  Chat0
• GSK Share
  Trades10
• GSK
  Live RNS0
• GSK Share
  Charts
• GSK Level 2
  Console
• GSK Live
  Share Price
• GSK Broker
  Ratings0
• GSK Directors
  Deals0
• GSK Financial
  Diary
• GSK
  Fundamentals
• GSK Short
  Positions0
• GSK
  Media0

• Buy GSK Shares
• Add GSK to Watchlist
• Add GSK to Alert

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 1,600.00

Bid: 1,570.00

Ask: 1,695.00

Change: 0.00 (0.00%)

Spread: 125.00 (7.962%)

Open: 0.00

High: 0.00

Low: 0.00

Prev. Close: 1,600.00

Last checked at -

• GSK News
• GSK Professional News

UK earnings, trading statements calendar - next 7 days

Wed, 19th Apr 2023 15:42

Thursday 20 April
AJ Bell PLC	Trading Statement
Arix Bioscience PLC	Full Year Results
Centamin PLC	Trading Statement
Deliveroo PLC	Trading Statement
Dianomi PLC	Full Year Results
Dunelm Group PLC	Q3 Results
Foxtons Group PLC	Trading Statement
GB Group PLC	Trading Statement
Hochschild Mining PLC	Full Year Results
Intelligent Ultrasound Group PLC	Full Year Results
Oxford BioMedica PLC	Full Year Results
PensionBee Group PLC	Trading Statement
Rentokil Initial PLC	Trading Statement
Rio Tinto PLC	Trading Statement
Senior PLC	Trading Statement
Segro PLC	Trading Statement
WH Smith PLC	Half Year Results
Friday 21 April
Angle PLC	Full Year Results
BHP Group Ltd	Trading Statement
Lookers PLC	Full Year Results
Monday 24 April
Brighton Pier Group PLC	Full Year Results
CentralNic Group PLC	Trading Statement
Checkit PLC	Full Year Results
Egdon Resources PLC	Half Year Results
Keystone Law Group PLC	Full Year Results
Lok'n Store Group PLC	Half Year Results
Novacyt SA	Full Year Results
Tuesday 25 April
AB Dynamics PLC	Half Year Results
Anglo American PLC	Trading Statement
Associated British Foods PLC	Half Year Results
Avacta Group PLC	Full Year Results
Banco Santander SA	Q1 Results
Card Factory PLC	Full Year Results
Coca-Cola Europacific Partners PLC	Trading Statement
Corero Network Security PLC	Full Year Results
Dillistone Group PLC	Full Year Results
Focusrite PLC	Half Year Results
hVIVO PLC	Full Year Results
IWG PLC	Trading Statement
Jadestone Energy PLC	Full Year Results
Next Fifteen Communications Group PLC	Full Year Results
Northcoders Group PLC	Full Year Results
Petrofac Ltd	Full Year Results
Quilter PLC	Trading Statement
Resolute Mining Ltd	Trading Statement
RWS Holdings PLC	Trading Statement
Travis Perkins PLC	Trading Statement
WAG Payment Solutions PLC	Trading Statement
Whitbread PLC	Full Year Results
Wednesday 26 April
1Spatial PLC	Full Year Results
Biome Technologies PLC	Full Year Results
Bunzl PLC	Q1 Results
C4X Discovery Holdings PLC	Half Year Results
CRH PLC	Trading Statement
Ecora Resources PLC	Trading Statement
Frenkel Topping Group PLC	Full Year Results
Fresnillo PLC	Trading Statement
Glencore PLC	Trading Statement
GSK PLC	Q1 Results
Home REIT PLC	Half Year Results
Learning Technologies Group PLC	Full Year Results
Man Group PLC	Trading Statement
RBG Holdings PLC	Full Year Results
Reckitt Benckiser Group PLC	Trading Statement
Sanderson Design Group PLC	Full Year Results
Smith & Nephew PLC	Trading Statement
Standard Chartered PLC	Q1 Results
Trifast PLC	Trading Statement
Warpaint London PLC	Full Year Results
Copyright 2023 Alliance News Ltd. All Rights Reserved.

17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more

16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more

16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more

16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more

16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more

15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more

10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more

10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more

10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more

9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more

9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more

9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more

8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more

8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more

8 Jan 2024 19:02

Moderna says it hit its 2023 COVID vaccine sales goal

Jan 8 (Reuters) - Moderna on Monday said its 2023 COVID vaccine sales would be around $6.7 billion, coming in above the lower end of its full-year forecast, and reiterated its goal of returning to sales growth in 2025.

Read more